Research & Innovation Unit

Mission

 

To engage with researchers to:

1. Transfer the knowledge developed at i3S to the Healthcare Ecosystem, involving relevant stakeholders in its valorisation and exploitation into knowledge-intensive products or services;

2. Attract competitive funding for research activities, with particular emphasis in international sources, providing comprehensive support to the integrative research programmes and individual researchers in their project applications.

3. Develop strategical interfaces with health-related industry and clinical centres to conceive and implement matched and innovative academic-industrial-clinical translational R&D Projects that fulfil clinical and healthcare needs;


 

01. Knowledge Transfer Office

 

Our Commitment

To transfer the knowledge developed at i3S to the Healthcare & Biotech Ecosystems by promoting its valorisation and commercial exploitation in the form of knowledge-intensive products or services.

 

Lines of Action

• Intellectual Property (IP) management (technology evaluation and IP strategies to market, patent registry) and Licensing.

• Scouting and selection of high potential technology-based entrepreneurial projects and management of tools to early-stage projects.

• Market access-related Regulatory issues and Certification of Medical Devices and In Vitro Diagnostics.

• Coordination of the Resolve-Health Innovation Acceleration Program.

• Creation and follow-up of spin-offs (Ideation, Business Plan writing, incubation support, business development, presentation to investors, management of the relationship with the Institute).

• Applications to Innovation awards/programs and Innovation Accelerator Programs.

• Provide management tools and support to the i3s scientific and technological services or platforms

 

Team members and areas of expertise and action:

- Hugo Prazeres (Office Coordinator): Registering and management of IP and Licensing to companies. Application to Innovation programs/awards, presentation to venture capital and investors. Entrepreneurship and support to creation of new spin-offs. Incubation and follow-up of spin-offs. Market access-related Regulatory issues and Certification of Medical Devices and In Vitro Diagnostics. Coordination of the RESOLVE-HEALTH Innovation Accelerator Program.

- João Cortez: Registering and management of IP, including patentability assessment and strategies for valorization, with focus on licensing on biomedical engineering technologies. Targeted support to promote the valorization and maturity of seed projects, and coordination of the RESOLVE-HEALTH program.


 

02. Research Funding Office

 

Our Commitment

To engage with i3S researchers in order to increase the capacity of the Institute to attract competitive funding for research activities, with particular emphasis in international sources, providing support to the integrative research programmes and individual researchers in their project applications.

 

Lines of action

The mission of the Research Funding Office (RFO) is fulfilled through the following actions:

1. Provide information on funding programmes by identifying and mapping open and forthcoming calls for proposals by national and international funding agencies, public or private (an updated Map of Funding Opportunities is available via the i3S Portal); match funding opportunities with researcher profiles.

2. Support researchers in the process of application to competitive funding calls launched by national and international funding programmes (e.g. P2020, H2020, etc.). Provide support in the application process, including full information on rules, and other activities as necessary.

3. Foster close and fruitful contacts with relevant funding bodies, in particular with the European Commission, Regional and National funding bodies, among others.

4. Provide support to PIs in the necessary documentation and procedures until contract signature, in liaison with the Project Management Offices.

5. Coordinate efforts with the Innovation and Industry Partnerships Unit in the evaluation of the knowledge and technologies identified, to ensure matching of the most appropriate type of funding available for each type and maturity of the knowledge/technology

 

Team members and areas of expertise and action

- João Cortez (Office Coordinator):  Support the preparation of international grant applications, and in particular H2020 applications (consortium building, writing and submission of the application). Liaison with the European Commission. Support to N2020 projects with the industry (writing). Undertake scouting actions. Liaise with the Knowledge Transfer Office (mapping of existing knowledge, technology and competences at i3S).

- Catarina Carona: Dissemination of calls for grants and projects. Development and maintenance of the Funding Opportunities and Submitted Proposals online databases. Support to R&D projects, both national and international, in matters of application procedures and guidelines. Liaison with FCT and other funding agencies. Liaison with the financial and administrative departments of i3S. Management and support to projects that require licenses for animal experimentation (liaison with researchers, CEA, DGAV).

- Isabel Menezes: Support to R&D national projects in matters of application procedures and guidelines. In particular, support the preparation of P2020 and N2020 grant applications (rules and submission of the applications in the respective platforms Balcão2020/PAS 2.0).


 

03. Translational Research & Industry Partnerships Office

 

Our Commitment

To engage with researchers aiming at promoting industry-academic-clinic R&D cooperative strategies and translational research studies in order to fulfil clinical and healthcare needs.

 

Lines of Action

1. Scientific and strategical conception, implementation and management of Contracted Research (Industry-sponsored R&D, clinical and translational projects).

2. Design and implementation of Investigator-Initiated clinical and non-clinical projects.

3. Scientific and clinical liaison with national and International pharma/biotech industry and clinical centres.

4. Support to applications to Open Innovation platforms.

5. Generation of translational academic-clinical consortia within the setting of European-related calls.

6. Integration in national and international networks of translational research.

 

Team members and areas of expertise and action:

- André Albergaria (Office Coordinator): Development of strategical interfaces with international pharma/biotech industry and clinical centres. Conception, implementation and management of Contracted Research (Industry-sponsored R&D clinical and translational projects). Support to Open Innovation platforms and to Investigator-Initiated clinical and non-clinical projects.

- Jorge Lima: Building of translational academic-clinical consortia for European funding (H2020-related clinical and translational research calls), active co-writing of proposals and their submission. Integration in national and international networks of translational research. Support to the scientific conception of Industry-sponsored R&D clinical and translational projects. Liaise with the Research Funding Unit in matters related to the abovementioned actions.